HHS Continues to Work on Transition of Paxlovid to Commerical Market

October 19, 2023

The U.S. Department of Health and Human Services (HHS) announced on October 13 that HHS and Pfizer have reached an agreement that will transition Paxlovid, the COVID-19 therapeutic, to the commercial market. 

Preparations for the transition will begin next month, but Paxlovid will remain available for ordering from HHS through December 15. 

Individuals on Medicare and Medicaid will access free government-procured Paxlovid through a patient assistance program through the end of 2024. Individuals who are uninsured or underinsured will access free government-procured Paxlovid through a patient assistance program through the end of 2028. 

Pfizer will operate a copay assistance program for those with private insurance through 2028. Pfizer has agreed to replenish any government-procured product that is about to expire with up-to-date product and has also agreed to provide HHS with a stockpile of 1 million treatment courses for future COVID-19 surges. 

HHS is working on additional details, particularly about the patient assistance program. Pfizer has not yet announced cost details for Paxlovid, but there is media speculation that the cost will be several times the current government negotiated price of $530/course. 

Latest News

Allina Health Physicians Vote to Authorize Strike

July 9, 2026

More than 130 Allina Health hospital physicians represented by Doctors Council SEIU voted last week, by a 90% margin, to authorize a strike after nearly two years of bargaining.  

MMA Launches New Program to Strengthen Physician Well-being

July 9, 2026

The MMA is launching a new program, exclusive to members, to strengthen physician well-being, reduce professional isolation, build a culture of connection, and foster sustained peer connections over time.  

State Pursuing Medicaid Expansion to Treat Incarcerated People

July 9, 2026

Minnesota is pursuing a new initiative that, if approved by the federal government, will allow state Medicaid programs to cover certain behavioral health services and medical care for chronic health conditions for incarcerated people, for up to 90 days before release.